Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

£14 Million Boost to Life Science Cluster at Milton Park, Oxford

Published: Wednesday, January 29, 2014
Last Updated: Wednesday, January 29, 2014
Bookmark and Share
A share of a £100 million Government cash injection is awarded to accelerate growth and jobs in Enterprise Zones across the UK.

Milton Park will receive a grant of up to £7 million to support the development of a £14 million, 40,000 sq ft specialist science centre for small and growing businesses within the life sciences sector. The balance of funding will be provided by park owners, MEPC. The new facility will be called the Milton Science Centre (MSc).

As part of today's announcement, Ed Vaizey Government Minister and Local MP visited Milton Park to deliver the good news and meet representatives from some of the 50 strong life sciences businesses already based at Milton Park.

Ed Vaizey was also shown around the laboratories of Immunocore, a privately owned, clinical-stage biotechnology company developing novel biological drugs to treat cancer and viral disease and a great example of a successful Oxfordshire Life Science Business. Ed Vaizey added: “Today’s announcement underlines this government's strong commitment to the UK life sciences sector. It will also lead to a significant step in the development of the Oxfordshire cluster. Milton Park is one of the top performing enterprise zones across the country and, with its new Local Development Order simplifying planning and track record of success,  I have every confidence that this project will be delivered quickly and help produce many more great life sciences businesses like Immunocore.”

James Dipple, Managing Director of Milton Park, explains, " This announcement is great news for Oxfordshire, as it will further strengthen the county's highly successful life sciences cluster.  The Government's contribution will help us build on the great environment we already have here and provide these small and growing life sciences businesses with the specialist accommodation they really need.  This is the culmination of a county wide team effort across the public and private sectors and I am grateful to all those who helped to support the bid.  A special thanks must go to the District and County Councils, the Local  Enterprise Partnership and OBN. I must also say a big thank you to our local MP Ed Vaizey. Public-private partnerships such as this, with business investing alongside Government, create opportunities for local employment, national success and healthcare advances which will be used around the world."

During the last six months, Immunocore has entered into major partnerships with leading pharmaceutical companies, Genentech, GlaxoSmithKline and MedImmune, part of AstraZeneca, and has doubled in size to nearly 100 staff.

Eva-Lotta Allan, Chief Business Officer at Immunocore, commented: "We welcome  the Government's decision to work in partnership with Milton Park to enhance the life science infrastructure within the Science Vale Enterprise Zone. Adding a dedicated hub for innovation to the existing facilities here, will help to ensure we continue to attract the best scientists as we progress the development of new treatments that could help many thousands of cancer patients."

Immunocore is one of the ten fastest growing life science companies based on Milton Park, featured in a publication launched by OBN earlier this month. The book, titled ‘An Evolution: The Story of Milton Park Life Sciences Cluster’, celebrates the life sciences cluster at Milton Park and includes interviews from senior personnel from each company.

Jon Rees, CEO of OBN, adds, “We were delighted to support this bid. The new facility will address a limiting step in Oxfordshire life sciences cluster and is exactly what it needs. The provision of wet labs for start-ups is the obvious next stage of evolution for the Milton Park life science cluster. ”



Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!